Madrigal Pharmaceuticals (MDGL) Return on Capital Employed Growth (5y) (2016 - 2026)
Madrigal Pharmaceuticals (MDGL) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,418.00 |
| Dec 31, 2025 | 4,749.00 |
| Sep 30, 2025 | 1,772.00 |
| Jun 30, 2025 | 190.00 |
| Mar 31, 2025 | -2,125.00 |
| Dec 31, 2024 | -3,364.00 |
| Sep 30, 2024 | -4,256.00 |
| Jun 30, 2024 | -4,050.00 |
| Mar 31, 2024 | -4,984.00 |
| Dec 31, 2023 | -11,015.00 |
| Sep 30, 2023 | -19,715.00 |
| Jun 30, 2023 | -14,201.00 |
| Mar 31, 2023 | -10,795.00 |
| Dec 31, 2022 | -17,558.00 |
| Sep 30, 2022 | -25,370.00 |
| Jun 30, 2022 | -11,252.00 |
| Mar 31, 2022 | -5,657.00 |
| Dec 31, 2021 | -4,529.00 |
| Sep 30, 2021 | -2,528.00 |
| Jun 30, 2021 | -5,680.00 |